Position
Column Group LLC in Oric Pharmaceuticals, Inc.
Back to the book · All holders of ORIC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $15.9M$8.18 → $12.67
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.54M | $29M | — | — | — | 35.0% |
| Q1 2026 | 3.54M | $44.9M | $12.67 | $15.9M | −$0 | 44.5% |